We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
AUM
$1.28B
AUM Growth
+$108M
Cap. Flow
+$48.1M
Cap. Flow %
3.75%
Top 10 Hldgs %
12.71%
Holding
333
New
42
Increased
153
Reduced
75
Closed
42

Sector Composition

Rank Sector Weight
1 Financials 17.22%
2 Industrials 15.31%
3 Consumer Discretionary 12.43%
4 Technology 12.29%
5 Healthcare 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
126
American Tower
AMT
$79.9B
$3.96M 0.31%
27,738
+18
+0.1% +$2.57K
COR icon
127
Cencora
COR
$62.2B
$3.91M 0.3%
42,569
-630
-1% -$52.1K
CNCE
128
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.83M 0.3%
+148,213
New +$2.98M
ENVA icon
129
Enova International
ENVA
$6.2B
$3.83M 0.3%
252,061
-40,352
-14% -$592K
ALTO icon
130
Alto Ingredients
ALTO
$345M
$3.81M 0.3%
837,047
+88,682
+12% +$420K
KDP icon
131
Keurig Dr Pepper
KDP
$42.3B
$3.75M 0.29%
38,599
+23
+0.1% +$2.06K
SRCE icon
132
1st Source
SRCE
$2.18B
$3.72M 0.29%
75,187
-1,148
-2% -$58.3K
UNH icon
133
UnitedHealth
UNH
$389B
$3.72M 0.29%
16,853
-331
-2% -$70.1K
JNPR
134
DELISTED
Juniper Networks
JNPR
$3.65M 0.28%
128,174
+75
+0.1% +$2.03K
CRAI icon
135
CRA International
CRAI
$1.16B
$3.64M 0.28%
81,013
+32,614
+67% +$1.43M
GCAP
136
DELISTED
Gain Capital Holdings, Inc.
GCAP
$3.61M 0.28%
360,953
-47,178
-12% -$338K
BMTC
137
DELISTED
Bryn Mawr Bank Corp
BMTC
$3.55M 0.28%
80,303
-2,968
-4% -$131K
HFWA icon
138
Heritage Financial
HFWA
$1.22B
$3.5M 0.27%
113,725
+80,933
+247% +$2.49M
WIRE
139
DELISTED
Encore Wire Corp
WIRE
$3.41M 0.27%
70,039
-1,015
-1% -$46.9K
FIT
140
DELISTED
Fitbit, Inc. Class A common stock
FIT
$3.33M 0.26%
582,592
-5,154
-0.9% -$32.8K
TITN icon
141
Titan Machinery
TITN
$458M
$3.33M 0.26%
157,085
-43,060
-22% -$740K
BCC icon
142
Boise Cascade
BCC
$2.83B
$3.32M 0.26%
83,272
+65,543
+370% +$2.43M
CMD
143
DELISTED
Cantel Medical Corporation
CMD
$3.26M 0.25%
31,727
+23,850
+303% +$2.38M
BRK.B icon
144
Berkshire Hathaway Class B
BRK.B
$1.11T
$3.22M 0.25%
16,265
+1,099
+7% +$209K
RSG icon
145
Republic Services
RSG
$66.6B
$3.1M 0.24%
45,829
+33
+0.1% +$2.13K
MA icon
146
Mastercard
MA
$497B
$3.08M 0.24%
20,370
DRH icon
147
Diamondrock Hospitality Co
DRH
$2.67B
$3.06M 0.24%
270,730
-20,501
-7% -$228K
WMB icon
148
Williams Companies
WMB
$85.8B
$2.97M 0.23%
97,560
-4,872
-5% -$142K
CRVL icon
149
CorVel
CRVL
$3.14B
$2.92M 0.23%
165,630
+12,726
+8% +$240K
PDLI
150
DELISTED
PDL BioPharma, Inc.
PDLI
$2.84M 0.22%
1,038,172
+996,002
+2,362% +$3.06M

Similar funds

Matarin Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Matarin Capital Management held 333 positions worth $1.28B, up 9.2% from $1.18B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Matarin Capital Management deployed $48.1M of net new capital in Q4 2017, opening 42 new positions and adding to 153 existing holdings. Its largest new stake was Hyster-Yale Materials Handling: 99,902 shares worth $8.51M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Atlas Air Worldwide Holdings, Inc., an estimated $9.17M trimmed.

  • Matarin Capital Management's largest Q4 2017 buy was Hyster-Yale Materials Handling: 99,902 shares worth $8.51M.
  • Matarin Capital Management added most to Myriad Genetics in Q4 2017, an estimated $11.3M increase.
  • Matarin Capital Management's biggest Q4 2017 reduction was Atlas Air Worldwide Holdings, Inc., cutting an estimated $9.17M.
  • Matarin Capital Management fully exited Sabra Healthcare REIT in Q4 2017, selling an estimated $9.24M.
  • Matarin Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q4 2017.
  • Matarin Capital Management opened 42 new positions and closed 42 in Q4 2017.
  • Matarin Capital Management's portfolio value rose 9.2% quarter-over-quarter to $1.28B.

Based on Matarin Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.